Healthtech Investors & VC Firms in Belgium

72 firms in this list, with a median first check of $1M. 24 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
TechVision Fonds 19 people · Leads rounds	Aachen	DE	Pre-Seed–Series A	$540K – $2.2M	+ Add to CRM
Ananda Impact Ventures 15 people · Leads rounds	Munich	DE	Pre-Seed–Series B	$540K – $3.2M	+ Add to CRM
Matterwave Ventures 11 people · Follows rounds	Munich	DE	Seed–Series A	$1.1M – $10.8M	+ Add to CRM
Finch Capital 13 people · Leads rounds	Amsterdam	NL	Series A–Growth	$5.4M – $16.2M	+ Add to CRM
AdBio partners 21 people	Paris	FR	Seed–Series A	—	+ Add to CRM
United Founders 26 people	Senningerberg	LU	—	—	+ Add to CRM
Debiopharm Innovation Fund 17 people · Leads rounds	Lausanne	CH	Pre-Seed–Series A	$1M – $5M	+ Add to CRM
Cottonwood Technology Fund 11 people · Leads rounds	Denver	US	Pre-Seed–Growth	$1M – $25M	+ Add to CRM
Invivo Capital Partners 13 people	Barcelona	ES	Pre-Seed–Series A	$2.2M – $4.3M	+ Add to CRM
Senovo 8 people	Munich	DE	Seed–Series A	$1.1M – $5.4M	+ Add to CRM
Boehringer Ingelheim Venture Fund 16 people	Ingelheim am Rhein	DE	Seed–Growth	$16.2M	+ Add to CRM
NextGen Ventures 16 people	Ede	NL	Growth	—	+ Add to CRM
EIT Digital Accelerator 5 people	Espoo	FI	Series A–Growth	$5M – $25M	+ Add to CRM
PAI Partners 13 people	Paris	FR	Growth–Late Stage	$108M – $324M	+ Add to CRM
New Rhein Healthcare Investors, LLC 15 people	Philadelphia	US	Series B–Late Stage	—	+ Add to CRM
Future Positive Capital 6 people · Follows rounds	—	FR	Pre-Seed–Series A	—	+ Add to CRM
Verto 9 people · Leads rounds	Paris	FR	Growth	$16.2M – $64.8M	+ Add to CRM
Aescap Life Sciences 14 people	Amsterdam	NL	Series A–Growth	—	+ Add to CRM
Connect Ventures 5 people · Leads rounds	London	GB	Pre-Seed–Series A	$500K – $5M	+ Add to CRM
Helsana HealthInvest AG 8 people	Dübendorf	CH	Series A–Series B	$1.1M – $5.5M	+ Add to CRM
Catalpa Ventures 10 people · Leads rounds	Grevenmacher	LU	Pre-Seed–Series A	$330K – $1.6M	+ Add to CRM
Ming capital 6 people	Shenzhen	CN	Seed–Series C	—	+ Add to CRM
Vesalius Biocapital III Partners SàRL 11 people	Contern	LU	Series B–Late Stage	$10.8M	+ Add to CRM
Novalis LifeSciences 9 people	Portsmouth	US	Seed–Late Stage	—	+ Add to CRM